A caspase-3 inhibitor prevented pulmonary injury induced by common bile duct ligation, an experimental model of hepatopulmonary syndrome, and decreased apoptosis and endothelial AQP1 levels [39]. The gene discussed is CASP3; the disease is hepatopulmonary syndrome.